GuidelineBMJ (Clinical research ed.)2022
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.
Qiukui Hao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
35 papers cite it
this paperpooled itcites it